[{"orgOrder":0,"company":"Russian Direct Investment Fund","sponsor":"Not Applicable","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"RUSSIA","productType":"Small molecule","year":"2020","type":"Not Applicable","leadProduct":"Favipiravir","moa":"RdRp","graph1":"Infections and Infectious Diseases","graph2":"Phase II\/ Phase III","graph3":"Russian Direct Investment Fund","amount2":0,"highestDevelopmentShortName":"Ph II\/III","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Oral","sponsorNew":"Russian Direct Investment Fund \/ Not Applicable","highestDevelopmentStatusID":"9","companyTruncated":"Russian Direct Investment Fund \/ Not Applicable"},{"orgOrder":0,"company":"Russian Direct Investment Fund","sponsor":"Not Applicable","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"RUSSIA","productType":"Small molecule","year":"2020","type":"Not Applicable","leadProduct":"Favipiravir","moa":"RdRp","graph1":"Infections and Infectious Diseases","graph2":"Phase II\/ Phase III","graph3":"Russian Direct Investment Fund","amount2":0,"highestDevelopmentShortName":"Ph II\/III","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Tablet","sponsorNew":"Russian Direct Investment Fund \/ Not Applicable","highestDevelopmentStatusID":"9","companyTruncated":"Russian Direct Investment Fund \/ Not Applicable"},{"orgOrder":0,"company":"Russian Direct Investment Fund","sponsor":"The Gamaleya National Center of Epidemiology and Microbiology","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"RUSSIA","productType":"Vaccine","year":"2020","type":"Not Applicable","leadProduct":"Gam-COVID-Vac","moa":"","graph1":"Infections and Infectious Diseases","graph2":"Approved","graph3":"Russian Direct Investment Fund","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"","sponsorNew":"Russian Direct Investment Fund \/ Gamaleya Research Institute of Epidemiology and Microbiology","highestDevelopmentStatusID":"12","companyTruncated":"Russian Direct Investment Fund \/ Gamaleya Research Institute of Epidemiology and Microbiology"},{"orgOrder":0,"company":"Russian Direct Investment Fund","sponsor":"The Gamaleya National Center of Epidemiology and Microbiology","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"RUSSIA","productType":"Vaccine","year":"2020","type":"Not Applicable","leadProduct":"Gam-COVID-Vac","moa":"","graph1":"Infections and Infectious Diseases","graph2":"Approved","graph3":"Russian Direct Investment Fund","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Intramuscular Injection","sponsorNew":"Russian Direct Investment Fund \/ The Gamaleya National Center Of Epidemiology And Microbiology","highestDevelopmentStatusID":"12","companyTruncated":"Russian Direct Investment Fund \/ The Gamaleya National Center Of Epidemiology And Microbiology"},{"orgOrder":0,"company":"Russian Direct Investment Fund","sponsor":"Not Applicable","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"RUSSIA","productType":"Vaccine","year":"2021","type":"Not Applicable","leadProduct":"Gam-COVID-Vac","moa":"","graph1":"Infections and Infectious Diseases","graph2":"Approved","graph3":"Russian Direct Investment Fund","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Intramuscular Injection","sponsorNew":"Russian Direct Investment Fund \/ Not Applicable","highestDevelopmentStatusID":"12","companyTruncated":"Russian Direct Investment Fund \/ Not Applicable"},{"orgOrder":0,"company":"Russian Direct Investment Fund","sponsor":"Not Applicable","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"RUSSIA","productType":"Vaccine","year":"2021","type":"Not Applicable","leadProduct":"rAd26","moa":"","graph1":"Infections and Infectious Diseases","graph2":"Approved","graph3":"Russian Direct Investment Fund","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Intramuscular Injection","sponsorNew":"Russian Direct Investment Fund \/ Not Applicable","highestDevelopmentStatusID":"12","companyTruncated":"Russian Direct Investment Fund \/ Not Applicable"},{"orgOrder":0,"company":"Russian Direct Investment Fund","sponsor":"Not Applicable","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"RUSSIA","productType":"Vaccine","year":"2021","type":"Not Applicable","leadProduct":"rAd26","moa":"","graph1":"Infections and Infectious Diseases","graph2":"Approved","graph3":"Russian Direct Investment Fund","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Intramuscular Injection","sponsorNew":"Russian Direct Investment Fund \/ Not Applicable","highestDevelopmentStatusID":"12","companyTruncated":"Russian Direct Investment Fund \/ Not Applicable"},{"orgOrder":0,"company":"Russian Direct Investment Fund","sponsor":"Not Applicable","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"RUSSIA","productType":"Vaccine","year":"2021","type":"Not Applicable","leadProduct":"rAd26","moa":"","graph1":"Infections and Infectious Diseases","graph2":"Approved","graph3":"Russian Direct Investment Fund","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Intramuscular Injection","sponsorNew":"Russian Direct Investment Fund \/ Not Applicable","highestDevelopmentStatusID":"12","companyTruncated":"Russian Direct Investment Fund \/ Not Applicable"},{"orgOrder":0,"company":"Russian Direct Investment Fund","sponsor":"Not Applicable","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"RUSSIA","productType":"Vaccine","year":"2021","type":"Not Applicable","leadProduct":"Gam-COVID-Vac","moa":"","graph1":"Infections and Infectious Diseases","graph2":"Approved","graph3":"Russian Direct Investment Fund","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Intramuscular Injection","sponsorNew":"Russian Direct Investment Fund \/ Not Applicable","highestDevelopmentStatusID":"12","companyTruncated":"Russian Direct Investment Fund \/ Not Applicable"},{"orgOrder":0,"company":"Russian Direct Investment Fund","sponsor":"Not Applicable","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"RUSSIA","productType":"Vaccine","year":"2021","type":"Not Applicable","leadProduct":"Gam-COVID-Vac","moa":"","graph1":"Infections and Infectious Diseases","graph2":"Approved","graph3":"Russian Direct Investment Fund","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Intramuscular Injection","sponsorNew":"Russian Direct Investment Fund \/ Not Applicable","highestDevelopmentStatusID":"12","companyTruncated":"Russian Direct Investment Fund \/ Not Applicable"},{"orgOrder":0,"company":"Russian Direct Investment Fund","sponsor":"Not Applicable","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"RUSSIA","productType":"Vaccine","year":"2021","type":"Not Applicable","leadProduct":"Gam-COVID-Vac","moa":"","graph1":"Infections and Infectious Diseases","graph2":"Approved","graph3":"Russian Direct Investment Fund","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Intramuscular Injection","sponsorNew":"Russian Direct Investment Fund \/ Not Applicable","highestDevelopmentStatusID":"12","companyTruncated":"Russian Direct Investment Fund \/ Not Applicable"},{"orgOrder":0,"company":"Russian Direct Investment Fund","sponsor":"AstraZeneca","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"RUSSIA","productType":"Vaccine","year":"2021","type":"Not Applicable","leadProduct":"ChAdOx1 nCoV-19","moa":"","graph1":"Infections and Infectious Diseases","graph2":"Undisclosed","graph3":"Russian Direct Investment Fund","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Intramuscular Injection","sponsorNew":"Russian Direct Investment Fund \/ AstraZeneca","highestDevelopmentStatusID":"1","companyTruncated":"Russian Direct Investment Fund \/ AstraZeneca"},{"orgOrder":0,"company":"Russian Direct Investment Fund","sponsor":"Not Applicable","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"RUSSIA","productType":"Vaccine","year":"2021","type":"Not Applicable","leadProduct":"rAd26","moa":"","graph1":"Infections and Infectious Diseases","graph2":"Approved","graph3":"Russian Direct Investment Fund","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Intramuscular Injection","sponsorNew":"Russian Direct Investment Fund \/ Not Applicable","highestDevelopmentStatusID":"12","companyTruncated":"Russian Direct Investment Fund \/ Not Applicable"},{"orgOrder":0,"company":"Russian Direct Investment Fund","sponsor":"AstraZeneca","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"UNITED KINGDOM","productType":"Vaccine","year":"2021","type":"Not Applicable","leadProduct":"ChAdOx1 nCoV-19","moa":"SARS-CoV-2 spike protein","graph1":"Infections and Infectious Diseases","graph2":"Approved","graph3":"Russian Direct Investment Fund","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Intramuscular Injection","sponsorNew":"Russian Direct Investment Fund \/ Russian Direct Investment Fund","highestDevelopmentStatusID":"12","companyTruncated":"Russian Direct Investment Fund \/ Russian Direct Investment Fund"},{"orgOrder":0,"company":"Russian Direct Investment Fund","sponsor":"Not Applicable","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"RUSSIA","productType":"Vaccine","year":"2021","type":"Not Applicable","leadProduct":"Gam-COVID-Vac","moa":"","graph1":"Infections and Infectious Diseases","graph2":"Approved","graph3":"Russian Direct Investment Fund","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Intramuscular Injection","sponsorNew":"Russian Direct Investment Fund \/ Not Applicable","highestDevelopmentStatusID":"12","companyTruncated":"Russian Direct Investment Fund \/ Not Applicable"},{"orgOrder":0,"company":"Russian Direct Investment Fund","sponsor":"AstraZeneca","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"RUSSIA","productType":"Vaccine","year":"2021","type":"Not Applicable","leadProduct":"ChAdOx1 nCoV-19","moa":"SARS-CoV-2 spike protein","graph1":"Infections and Infectious Diseases","graph2":"Phase II","graph3":"Russian Direct Investment Fund","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Intramuscular Injection","sponsorNew":"Russian Direct Investment Fund \/ AstraZeneca","highestDevelopmentStatusID":"8","companyTruncated":"Russian Direct Investment Fund \/ AstraZeneca"},{"orgOrder":0,"company":"Russian Direct Investment Fund","sponsor":"Not Applicable","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"RUSSIA","productType":"Vaccine","year":"2021","type":"Not Applicable","leadProduct":"Gam-COVID-Vac","moa":"","graph1":"Infections and Infectious Diseases","graph2":"Approved","graph3":"Russian Direct Investment Fund","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Intramuscular Injection","sponsorNew":"Russian Direct Investment Fund \/ Not Applicable","highestDevelopmentStatusID":"12","companyTruncated":"Russian Direct Investment Fund \/ Not Applicable"},{"orgOrder":0,"company":"Russian Direct Investment Fund","sponsor":"Stelis Biopharma","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"INDIA","productType":"Vaccine","year":"2021","type":"Not Applicable","leadProduct":"rAd26","moa":"","graph1":"Infections and Infectious Diseases","graph2":"Approved","graph3":"Russian Direct Investment Fund","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Intramuscular Injection","sponsorNew":"Russian Direct Investment Fund \/ RDIF","highestDevelopmentStatusID":"12","companyTruncated":"Russian Direct Investment Fund \/ RDIF"},{"orgOrder":0,"company":"Russian Direct Investment Fund","sponsor":"The Gamaleya National Center of Epidemiology and Microbiology","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"RUSSIA","productType":"Vaccine","year":"2022","type":"Not Applicable","leadProduct":"Gam-COVID-Vac","moa":"","graph1":"Infections and Infectious Diseases","graph2":"Approved","graph3":"Russian Direct Investment Fund","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Intramuscular Injection","sponsorNew":"Russian Direct Investment Fund \/ Russian Direct Investment Fund","highestDevelopmentStatusID":"12","companyTruncated":"Russian Direct Investment Fund \/ Russian Direct Investment Fund"},{"orgOrder":0,"company":"Russian Direct Investment Fund","sponsor":"Not Applicable","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"RUSSIA","productType":"Vaccine","year":"2022","type":"Not Applicable","leadProduct":"Gam-COVID-Vac","moa":"","graph1":"Infections and Infectious Diseases","graph2":"Approved","graph3":"Russian Direct Investment Fund","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Intramuscular Injection","sponsorNew":"Russian Direct Investment Fund \/ Not Applicable","highestDevelopmentStatusID":"12","companyTruncated":"Russian Direct Investment Fund \/ Not Applicable"},{"orgOrder":0,"company":"Russian Direct Investment Fund","sponsor":"Dr. Reddy's Laboratories","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"INDIA","productType":"Vaccine","year":"2022","type":"Not Applicable","leadProduct":"rAd26","moa":"","graph1":"Infections and Infectious Diseases","graph2":"Approved","graph3":"Russian Direct Investment Fund","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Intramuscular Injection","sponsorNew":"Russian Direct Investment Fund \/ RDIF","highestDevelopmentStatusID":"12","companyTruncated":"Russian Direct Investment Fund \/ RDIF"},{"orgOrder":0,"company":"Russian Direct Investment Fund","sponsor":"Dr. Reddy's Laboratories","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"INDIA","productType":"Vaccine","year":"2021","type":"Not Applicable","leadProduct":"Gam-COVID-Vac","moa":"SARS-CoV-2-viral spike protein","graph1":"Infections and Infectious Diseases","graph2":"Approved","graph3":"Russian Direct Investment Fund","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Injectable\/Injection","sponsorNew":"Russian Direct Investment Fund \/ Russian Direct Investment Fund","highestDevelopmentStatusID":"12","companyTruncated":"Russian Direct Investment Fund \/ Russian Direct Investment Fund"},{"orgOrder":0,"company":"Russian Direct Investment Fund","sponsor":"Strides Pharma Science","pharmaFlowCategory":"D","therapeuticArea":"Infections and Infectious Diseases","country":"INDIA","productType":"Vaccine","year":"2021","type":"Partnership","leadProduct":"Covid Vaccine","moa":"","graph1":"Infections and Infectious Diseases","graph2":"Approved","graph3":"Russian Direct Investment Fund","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Injection","sponsorNew":"Russian Direct Investment Fund \/ Russian Direct Investment Fund","highestDevelopmentStatusID":"12","companyTruncated":"Russian Direct Investment Fund \/ Russian Direct Investment Fund"}]
Find Clinical Drug Pipeline Developments & Deals by Russian Direct Investment Fund
Details :
Sputnik Light is a single-dose vaccine and the same as the first component -- recombinant human adenovirus serotype number 26 (rAd26) -- of the two-dose Sputnik V vaccine.
Details :
Sputnik V and Sputnik Light are based on a safe and effective human adenoviral vector platform and have not been associated with rare serious adverse events following vaccination, such as myocarditis or pericarditis.
Details :
Sputnik V (Gam-COVID-Vac), shows significantly smaller (2.6 times) reduction of virus-neutralizing activity against Omicron as compared to the reference Wuhan variant than Pfizer vaccine (8.1-fold reduction for Sputnik V in contrast to 21.4-fold reductio...
Details :
Sputnik Light (rAd26) vaccine demonstrates 91.6% efficacy rate against coronavirus, the world’s first registered vaccine against the novel coronavirus infection, is now approved for use in over 50 countries.
Details :
Cambodia has become the 71st country in the world to register the Russian vaccine. Sputnik V was granted an emergency use authorization. The one-shot Sputnik Light vaccine is based on the human adenovirus serotype 26, the first component of Sputnik V.
Details :
Sputnik V's efficacy against infection with the Delta variant is 83% and 94% against hospitalization. To date Sputnik V has been registered in 70 countries in various parts of the world with total population of over 4 billion people.
Details :
Preliminary results show combination of vaccine cocktail of AstraZeneca's ChAdOx1 nCoV-19 vaccine (AZD1222) and Sputnik Light vaccines demonstrate high immunogenicity profile in clinical study and high safety profile with no serious adverse events.
Details :
According to the study in the Province of Buenos Aires, the first component of Sputnik V (Sputnik Light) has shown 78.6-83.7% efficacy against COVID-19 in high-risk elderly subjects which is significantly higher than efficacy demonstrated by most two-com...
Details :
The efficacy of Sputnik V was measured based on the monitoring of COVID cases between 25 February and 23 August, 2021. Sputnik V is the most efficient vaccine against hospitalizations with COVID-19 in the country.
Details :
The Sputnik Light vaccine is based on a well-studied human adenoviral vector platform that has proven to be safe and effective, with no long-term side effects, as confirmed in over 250 clinical trials conducted globally over the past two decades .
Reset All
